Takeda Vows Appeal of $885M Jury Verdict in ‘Pay-for-Delay’ Antitrust CaseNews DeskMay 22, 20260 Most disputes between pharmaceutical companies and generic drugmakers end in settlements. Five years of class-action litigation over a Takeda Pharmaceutical…